Quotient Sciences wins multiple categories in 2021 CRO Leadership Awards
Content: Quotient has been recognized with multiple 2021 CRO Leadership Awards, including two Champion Awards. The CRO Leadership Awards recognizes top performing outsourcing organizations in the drug development arena. Quotient received leadership awards in five of the overall six categories.
Quotient featured in Drug Development & Delivery's Solubility Special Feature Report
Quotient Sciences was featured in Drug Development & Delivery's Special Feature article entitled: "Improving Bioavailability & Solubility: Each Molecule Is Unique."
Quotient Sciences Recognized as Top Pharma and Life Sciences Outsourcing Company
Quotient Sciences, a global drug development and manufacturing organization has been recognized as a “Top Pharma and Life Sciences Outsourcing Services Company in the UK for 2020” by PharmaTech Outlook magazine.
ANA Therapeutics and Quotient Sciences Announce Partnership to Manufacture Niclosamide Drug Candidate as a Potential Treatment for COVID-19
Quotient and ANA Therapeutics announce partnership to develop drug candidate, ANA001 (niclosamide capsules) as a potential treatment for COVID-19.
Quotient Sciences Completes Million Dollar Pharmacy Expansion at Miami Clinic
State-of-the-Art Compounding Pharmacy Will Accelerate Early Development Programs